Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Impairment of antioxidant defenses as a contributor to arsenite-induced cell transformation.

Authors: Wu, Jing; Sowinska, Anna; Huang, Xi; Klein, Catherine B; Pelle, Edward; Frenkel, Krystyna

Published In Biometals, (2012 Oct)

Abstract: Arsenite (As) causes transformation of human osteogenic sarcoma cells (HOS) when applied continuously at low doses (0.1-0.5 μM) during 8-weeks of exposure. However, the mechanisms by which As transforms human cells are not known. We investigated whether alterations occurred in gene expression and protein levels of antioxidant defense proteins, such as superoxide dismutase 1 (SOD1) and ferritin. In comparison to control HOS cells, 0.1 μM As induced greater cell proliferation and decreased anti-oxidant defenses. The tumor suppressor protein p53 was also decreased at both mRNA and protein levels. Further, pig3 (p53-induced-gene 3), a homolog of NQO1 (NADPH quinone oxidoreductase 1), was also down-regulated after 8 weeks of As challenge. The treatment of HOS cells with dicumarol, a NQO1 inhibitor, caused a dose-dependent decline in p53 protein levels, proving the effect of an antioxidant enzyme on p53 expression and, potentially, down-stream processes. Caffeic acid phenethyl ester, an antioxidant, prevented the As-induced decreases in SOD1, p53, and ferritin mRNA and protein levels. SOD1, p53 and ferritin levels were inversely related to As-induced cell proliferation. Cumulatively, these results strongly suggest that impairment in antioxidant defenses contributes to As-induced human cell transformation and that the p53 pathway is involved in the process.

PubMed ID: 22692362 Exiting the NIEHS site

MeSH Terms: Antioxidants/metabolism*; Arsenites/toxicity*; Caffeic Acids/pharmacology; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic/drug effects*; Cell Transformation, Neoplastic/genetics; Cell Transformation, Neoplastic/metabolism; Dicumarol/pharmacology; Environmental Pollutants/toxicity; Ferritins/genetics; Ferritins/metabolism; Gene Expression/drug effects; Genes, p53/drug effects; Humans; Intracellular Signaling Peptides and Proteins/genetics; Intracellular Signaling Peptides and Proteins/metabolism; Models, Biological; NAD(P)H Dehydrogenase (Quinone)/antagonists & inhibitors; Oxidative Stress/drug effects; Phenylethyl Alcohol/analogs & derivatives; Proto-Oncogene Proteins/genetics; Proto-Oncogene Proteins/metabolism; RNA, Messenger/genetics; RNA, Messenger/metabolism; Superoxide Dismutase-1; Superoxide Dismutase/genetics; Superoxide Dismutase/metabolism; Tumor Suppressor Protein p53/genetics; Tumor Suppressor Protein p53/metabolism

to Top